Provider
Vowst (fecal microbiota spores, live-brpk) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Documents & Forms Results
Displaying 3191 - 3200 of 3623 results
Provider
Winlevi (clascoterone) - Commercial
Prior Authorization
Program effective Date: Dec 01, 2025
Provider
Pancreatic Enzymes - Commercial
Step Therapy
Program effective Date: Jun 01, 2025
Provider
Lyrica (pregabalin) Savella (milnacipran) - Commercial
Step Therapy, Quantity Limit
Program effective Date: Jun 01, 2025
Provider
Furoscix (furosemide) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Provider
Attention Deficit [Hyperactivity] Disorder (ADHD/ADD) Agents - Commercial
Quantity Limit
Program effective Date: Jun 01, 2025
Provider
Low Molecular Weight Heparins (LMWH) and Arixtra - Commercial
Quantity Limit
Program effective Date: Jul 01, 2025
Provider
Urinary Incontinence - Commercial
Quantity Limit
Program effective Date: Oct 01, 2025
Provider
Tezspire (tezepelumab-ekko) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2025
Provider
Furoscix (furosemide) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025